baber/WOPTO huggingface dataset:
Patent AU-2003301740-B2 (AU)
Title: Multi- tiered Virtual Local Area Network (VLAN) domain mapping mechanism
Inventor: SILVA SURAN SAMINDA DE
IPC: H04L12/56
Filed: 2003-10-27
Granted: 2009-06-11
Abstract: In one embodiment, a first port of a device provides connectivity to a customer network and a second port of the device provides connectivity to a provider network. Frame mapping logic associated with the first port processes a network message received at the first port and accesses a Virtual Local Area Network (VLAN) mapping data structure that maps customer VLAN designations used in the customer network to provider VLAN designations used in the provider network. Frame mapping logic uses the VLAN mapping data structure to associate the received network message with a particular provider VLAN designation based upon the received network message's particular customer VLAN designation. The received network message is then passed toward the second port.
Patent AU-2004229824-B2 (AU)
Title: Method and device of port test of broad band access device in the digital subscriber broad band access system
Inventor: ZHOU JUN
IPC: H04L12/70
Filed: 2004-04-15
Granted: 2008-07-10
Abstract: The present invention discloses a method and apparatus for port test of a broadband access device in a digital subscriber line broadband access system. The method comprises: A) transmitting signals over the downstream channel of a port of a broadband access device in CO; B) the upstream channel of the port receiving and processing the reflected signals to obtain the test result of the port. In accordance with this invention, an internal test of the port of a broadband access device can be implemented without external testing devices or personnel or site.
Patent AU-2004254190-B2 (AU)
Title: Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
Inventor: BOSMANS JEAN-PAUL RENE MARIE ANDRE
IPC: C07D405/12
Filed: 2004-06-10
Granted: 2010-04-22
Abstract: The present invention is concerned with novel compounds of formula (I) having 5HT4-antagonistic properties. The invention further relates to methods for preparing such novel compounds, pharmaceutical compositions comprising said novel compounds as well as the use as a medicine of said compounds.
Patent AU-2004283431-B2 (AU)
Title: Transdermal pharmaceutical formulation for minimizing skin residues
Inventor: GRENIER ARNAUD
IPC: A61K47/38
Filed: 2004-10-06
Granted: 2009-09-10
Abstract: This invention relates to novel transdermal or transmucosal pharmaceutical formulation having an active agent of testosterone which reduces the occurrences of contamination of other individuals and the transference to clothing of the user. The solvent system of the formulation includes a monoalkylether of diethylene glycol and a glycol present in specified ratios, and a mixture of water and alcohol. The invention also relates to a method for inhibiting or delaying crystallization of the active agent in a pharmaceutical formulation.
Patent AU-2004320526-B2 (AU)
Title: Method for at least partially compensating for errors in ink dot placement due to erroneous rotational displacement
Inventor: PLUNKETT RICHARD THOMAS
IPC: B41J2/05
Filed: 2004-05-27
Granted: 2008-08-07
Abstract: A printhead module includes at least one row of printhead nozzles. Each row includes at least one displaced row portion. The displacement of the row portion includes a component in a direction normal to that of a pagewidth to be printed.
Patent AU-2005217237-B2 (AU)
Title: Anti-human tenascin monoclonal antibody
Inventor: RITA DE SANTIS
IPC: C07K16/30
Filed: 2005-02-16
Granted: 2011-12-22
Abstract: An anti-human tenascin monoclonal antibody is described, whose light and heavy chain variable region sequences are SEQ ID NO: 1 and SEQ ID NO: 2, respectively, its proteolytic fragments capable of binding to an antigenic epitope within the region A-D of human tenascin, its recombinant derivatives, its conjugates and its similar functional analogues capable of binding to an antigenic epitope within the A-D region of human tenascin.
Patent AU-2005228909-B2 (AU)
Title: Housing for harmonic generation crystals in solid state laser systems
Inventor: PHILIP SAARLOOS PAUL VAN
IPC: A61F9/008
Filed: 2005-03-29
Granted: 2011-10-06
Abstract: Apparatus for effecting harmonic conversion of a laser beam of predetermined frequency to provide plural harmonic components of the laser beam at frequencies different from the predetermined frequency, includes a housing (40) defining a hermetically sealed chamber able to be maintained at a pressure below atmospheric pressure. Also provided are port means for evacuating the chamber, and means (36, 37) defining an optical path for the laser beam and the components thereof through the housing and the chamber. A plurality of individual holders (20, 22, 24) are arranged for retaining respective frequency conversion crystals at spaced locations in the optical path. The crystals (20, 22, 24) can be individually aligned and heated within the chamber.
Patent AU-2005304333-B2 (AU)
Title: Intervertebral spacer
Inventor: O'BRIEN MICHAEL F
IPC: A61F2/44
Filed: 2005-11-10
Granted: 2011-07-21
Abstract: An interbody spacer (10) for insertion between vertebral members. The spacer includes a body having posterior and anterior sides (13,14) , and inferior and superior faces (17,18) . The spacer further includes a plurality of teeth (30) to maintain the position of the spacer between the vertebral members. The teeth are aligned in a pattern and have a shape to allow insertion into the space between the vertebral members, and prevent or limit movement once the spacer is positioned in the space.
Patent AU-2005311732-B2 (AU)
Title: Use of polyoxypropylene/polyoxyethylene terpene compounds in emulsion polymerization
Inventor: TILLOTSON ROBERT J
IPC: C09K23/52
Filed: 2005-12-02
Granted: 2010-12-09
Abstract: The invention relates to the use, in emulsion polymerization, of at least a compound derived from a terpene and comprising a number of oxypropylene units ranging between 0 to 20, and a number of oxyethylene units ranging between 2 to 80.
Patent AU-2006210690-B2 (AU)
Title: Optimum multifrequency electromagnetic signal for sea bed logging
Inventor: SCHAUG-PETTERSEN TOR
IPC: G01V3/30
Filed: 2006-01-27
Granted: 2012-03-22
Abstract: Multifrequency electromagnetic signals which may be used in the field of sea bed logging, the signal being optimised for use at a particular site, in order to greatly improve data inversion, and a method for producing the optimum multifrequency signal.
Patent AU-2006239221-B2 (AU)
Title: Pharma-informatics system
Inventor: PIKELNY ALEKSANDR
IPC: A61K9/48
Filed: 2006-04-28
Granted: 2012-03-15
Abstract: Compositions, systems and methods that allow for the detection of the actual physical delivery of a pharmaceutical agent to a body are provided. Embodiments of the compositions include an identifier and an active agent. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
Patent AU-2006264100-B2 (AU)
Title: Articulated climbing plate for a climbing shuttering
Inventor: SCHWORER ARTUR
IPC: E04G11/28
Filed: 2006-06-20
Granted: 2009-05-28
Abstract: A climbing shoe (10) comprises a sliding shoe section (16) and wall shoe section (18). The sliding shoe section (16) is designed so that it can guide and hold a climbing rail. The wall shoe section (18) is connected to the sliding shoe section (16) in an articulated manner.
Patent AU-2006271693-B2 (AU)
Title: Method for extracting lactic acid from aqueous suspensions
Inventor: LEBKUCHER HELMUT
IPC: C07C59/08
Filed: 2006-07-17
Granted: 2011-09-08
Abstract: The invention relates to a method for the continuous extraction of lactic acid from an aqueous suspension containing solids. According to said method, the aqueous suspension containing solids is brought into contact, in a counter-current, with an organic solvent that is partially miscible with water, in a column provided with filling agents which have a surface consisting of a hydrophobic material, in such a way as to form an aqueous phase and an organic phase, such that the organic phase is guided as a dispersed phase in a section of the column comprising filling agents.
Patent AU-2006299655-B2 (AU)
Title: Dual-chamber solution packaging system
Inventor: MARKWARDT KERRY L
IPC: A61J1/00
Filed: 2006-09-28
Granted: 2012-07-26
Abstract: A solution packaging system (10) is disclosed. One embodiment of the solution packaging system of the present invention comprises a gas-impermeable dual-chamber bag (15) , having a first chamber (30) and a second chamber (35) separated by a frangible (releasable) seal (25) , and an over-wrap member (20) enclosing and containing the dual-chamber inner bag. The dual-chamber bag can be used to package two-part medicinal solutions containing bicarbonate, such as ophthalmic irrigation solutions. The over-wrap member can serve as a dust cover and need not be a moisture or gas barrier, as the dual-chamber inner bag will have sufficient gas barrier properties to minimize the loss of CO2 from the first part of the solution (, the bicarbonate) . The dual-chamber bag can be fitted with an administration port (110) , and sealed with a stopper and an aluminum crimp seal. The dual-chamber bag can further comprise fill-ports (100) to fill each chamber. The fill port openings can be sealed after filling the chambers and the fill ports cut from the dual-chamber bag. The frangible seal between the chambers of the embodiments of this invention can be broken by the end user to mix and reconstitute the two parts of the solution prior to use.
Patent AU-2006308469-B2 (AU)
Title: In-line salt refining of molten aluminium alloys
Inventor: LAKRONI CARL
IPC: C22B9/05
Filed: 2006-10-25
Granted: 2011-09-08
Abstract: The present invention describes an apparatus and a process for in-line substantially continuous degassing of aluminium and/or aluminium alloys, in absence of chlorine and through the injection of at least one metal halide salt that includes a halogen and water and an inert gas, in a transfer trough before casting.
Patent AU-2007246213-B2 (AU)
Title: A gravity gradiometer
Inventor: VAN KANN FRANK JOACHIM
IPC: G01V7/08
Filed: 2007-08-14
Granted: 2013-07-04
Abstract: Abstract The present invention provides a gravity gradiometer for measuring components of the gravity gradient tensor. The 5 gravity gradiometer comprises at least one sensor mass for movement in response to a gravity gradient and a sensor and actuator unit for generating an electrical signal in response to the movement of the at least one sensor mass and for influencing the movement of the at least one 10 sensor mass. The gravity gradiometer also comprises an electronic circuit for simulating an impedance. The electrical circuit is arranged for amplifying the electrical signal received from the sensor and actuator unit and for directing an actuating signal to the sensor 15 and actuator unit. The electronic circuit comprises a differential amplifiers having first and second amplifier input terminals and an amplifier output terminal and impedances Zi, Z2 , Z3 , at least one of the impedances have an imaginary impedance component.
Patent AU-2007281038-B2 (AU)
Title: Methods and compositions for inhibiting angiogenesis
Inventor: WAYTE KENNETH MICHAEL
IPC: A61P27/02
Filed: 2007-08-03
Granted: 2012-11-15
Abstract: The present invention relates to a method of inhibiting angiogenesis in a biological system. The method includes administering to the biological system an effective amount of a steroid saponin.
Patent AU-2007291862-B2 (AU)
Title: Method of loadflow computation for electrical power system
Inventor: PATEL SURESHCHANDRA
IPC: H02B15/00
Filed: 2007-08-27
Granted: 2012-08-23
Abstract: A method of performing loadflow calculations for controlling voltages and power flow in a power network by reading on-line data of given/specified/scheduled/set network variables/parameters and using control means, so that no component of the power network is overloaded as well as there is no over/under voltage at any nodes in the network following a small or large disturbances. A loadflow calculation method could be any method including invented Patel Decoupled Loadflow (PDL) method, and Decoupled Gauss-Seidel-Patel Loadflow (DGSPL) method. The invented Patel Decoupled Loadflow (PDL) calculation method is characterized in 1) the use of the same coefficient matrix [GB] for both the p-f and q-e sub-problems of the loadflow calculation; 2) almost no effort in the modified mismatch calculations in the iteration process; and 3) all the nodes in both the sub-problems being active, no refactorization of [GB] required for implementation of Q-limit violations. These features make the invented PDL method computationally almost two times more efficient than the current state-of-the-art Super Super Decoupled Loadflow (SSDL) method. It is also possible to organize the RP-f, and RQ-e sub-problems for solution by Gauss-Seidel iterations. The invented DGSPL calculation method is characterized in decoupling the calculation of real and imaginary components of complex node voltage leading to increased stability and efficiency of the DGSPL calculation method.
Patent AU-2007311419-B2 (AU)
Title: A floatable wave energy converter and a method for improving the efficiency of a floatable wave energy converter
Inventor: MCCARTHY MICHAEL JOHN MARTIN
IPC: F03B13/14
Filed: 2007-10-18
Granted: 2014-03-20
Abstract: A wave energy converter (1) comprises a housing (2) extending between a forward end (3) and an aft end (4). Three upstanding air chambers (15) are located in the housing (2) and three corresponding water accommodating ducts (16) extend aft from the air chambers (15) and terminate in aft water accommodating openings (17) for accommodating water into and out of the air chambers (15) as the housing (2) oscillates by pitching in response to passing waves. An air accommodating duct (21) communicates with the air chambers (15) through a manifold (20) for accommodating air into and out of the air chambers (15) as the water level (19a) falls and rises within the air chambers (15) as the housing (2) oscillates. A self-rectifying turbine (22) located in the air accommodating duct (21) powers an electrical generator (24) for generating electricity. A buoyancy tank (31) is located on the housing (2) above the water accommodating ducts (16) aft of the air chambers (15) for maintaining the housing (2) floating in the water. A first stabilising plate (28) extending in a generally forwardly downwardly direction extends from a lower sloping portion (27) at the forward end (3) of the housing (2) for controlling the pitching oscillating motion of the housing (2) relative to wave motion for in turn enhancing the power output produced by the converter (1). A forward ballast tank (31) and a pair of second stabilising plates (30) extending upwardly from the housing (2) enhance the stability of the converter (1).
Patent AU-2008212816-B2 (AU)
Title: Novel antagonists of the glucagon receptor
Inventor: REDDY RAJA K
IPC: C07C311/08
Filed: 2008-02-11
Granted: 2014-08-07
Abstract: The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity. The present invention further provides for pharmaceutical compositions comprising the same as well as methods of treating, preventing, delaying the time to onset or reducing the risk for the development or progression of a disease or condition for which one or more glucagon receptor antagonist is indicated, including Type I and II diabetes, insulin resistence and hyperglycemia. The present invention also provides for processes of making the compounds of Formula I, including salts and co-crystals thereof, and pharmaceutical compositions comprising the same.
Patent AU-2008213323-B2 (AU)
Title: Cellulose derivative and method for production thereof
Inventor: FUKUHIRA YUKAKO
IPC: C08B11/14
Filed: 2008-02-06
Granted: 2012-05-24
Abstract: Disclosed are: a cellulose derivative having a repeating unit represented by the formula below; a composition comprising the cellulose derivative and a phospholipid; a method for production of the cellulose derivative or the composition; and an anti-adhesive agent comprising the derivative or the composition. wherein R, R and R independently represent -H, -CH-COOH, -CH-COOX or -CHCO-phosphatidylethanolamine; and X represents an alkali metal or an alkali earth metal, provided that the sum total of the substitution degrees of -CH-COOH and -CH-COOX is 0.3 to 2.0 and the substitution degree of -CHCO-phosphatidylethanolamine is 0.001 to 0.05.
Patent AU-2008214626-B2 (AU)
Title: Method for exchanging structural components for an automation system
Inventor: DREBINGER ANDREAS
IPC: G05B19/05
Filed: 2008-02-14
Granted: 2011-05-12
Abstract: According to the invention, during continuous operation of an automation system, one type of structural component is initially modified by a projection tool in the surroundings of the projection, independently of the start of operation of the structural component and a characteristic of the type is maintained in a constant manner. The instance the structural component is replaced in the function plan by the modified structural component and the structural modifications are correspondingly recorded. The exchanged structural component is transmitted into the automation system, parallel to the continuous operation of the automation system and without repercussions thereon. The uninterrupted switching to the configuration takes into account the exchanged structural component such that the modified and exchanged structural component is activated in the automation system.
Patent AU-2008219334-B2 (AU)
Title: Stapedius muscle electrode
Inventor: SCHMIDT WOLFRAM
IPC: A61B5/296
Filed: 2008-02-19
Granted: 2010-10-28
Abstract: The invention relates to a stapedius muscle electrode array for detecting the action elements generated when a human stapedius muscle is contracted. Said array comprises an electrode (2, 2′, 2″) that is adapted for bipolar discharge and is to be attached to a human stapedius muscle. The electrode has two flexible, elastic, electrically conducting elongate elements (2a, 2b), each of which has a distal (4a, 4b) and a proximal end (17a, 17b) and is helically preshaped along at least some of the length thereof to the distal end (4a, 4b) thereof in such a way that the distal end (4a, 4b) and a section of the respective elongate element (2a, 2b) which adjoins the distal end (4a, 4b) can be placed at least in part around the tendon (7) extending between the stapedius muscle and the stapes while the helical part can be guided along the tendon (7), can be moved in the direction of the stapedius muscle, and can be at least partly twisted into and/or slid onto the region of the muscle belly (6) adjoining the tendon (7). The two elongate elements (2a, 2b) are electrically insulated from one another, and the helical parts (3) thereof are intertwined in such a way as to run around a common centerline (11), allowing the helical parts (3) to be jointly placed around the tendon (7), be guided along the tendon (7), and be brought in contact with the stapedius muscle.
Patent AU-2008223387-B2 (AU)
Title: Wound closure material
Inventor: OSTAPOFF ROLAND
IPC: B29C48/32
Filed: 2008-03-05
Granted: 2014-03-06
Abstract: Articles are provided having no orientation or a multi-directional orientation. Such articles may be in the form of films, ribbons, sheets, and/or tapes and may be utilized as buttresses with a surgical stapling apparatus or as reinforcing means for suture lines.
Patent AU-2008246210-B2 (AU)
Title: Loading mechanism for infusion pump
Inventor: RICHARD LANIGAN
IPC: A61M5/158
Filed: 2008-11-14
Granted: 2011-09-15
Abstract: Abstract A loading mechanism for a medication infusion pump. The mechanism includes a medication reservoir, a plunger, a 5 threaded plunger rod offset from the axis of the reservoir and an infusion pump with a drive screw that is offset from the axis of a pump barrel. The pump barrel receives the assembly comprising the reservoir, plunger and plunger rod. N:\Melboume\Cases\Patent\53000-53999\P53567.AU.1\Specis\P53567.AU.1 Specification 2008-11-14.doc 14/11/08 WO 03/059420 PCT/USO2/41361 C) toc CD l ~ ci0
Patent AU-2008283242-B2 (AU)
Title: Process for producing toluidine compound
Inventor: YOSHIZAWA HIROSHI
IPC: C07D213/72
Filed: 2008-07-29
Granted: 2012-06-28
Abstract: Because fluazinam is excellent as an active ingredient of pesticides and highly useful, it is desired to produce it efficiently in a proper form with simple operations at low cost in an environmentally friendly manner. The desired product is obtained in good yields with simple operations by using industrially advantageous reaction systems by a process comprising (1) a step of reacting ACTF and DCDNBTF in the presence of an alkali component, a solvent selected from the group consisting of ketones, nitriles, ethers and esters and a sufficient amount of water to substantially dissolve the alkali component, (2) a step of neutralizing or acidifying the reaction mixture with an acid and (3) a step of removing the solvent by distillation from the mixture containing fluazinam as the reaction product and the reaction solvent to precipitate crystals the product.
Patent AU-2008287831-B2 (AU)
Title: Novel salt of isoquinoline compound and crystal thereof
Inventor: TANAKA TOSHIHIKO
IPC: A61P43/00
Filed: 2008-08-08
Granted: 2013-05-23
Abstract: A novel salt form of (R)-3-[2-(2-hydroxymethylpyrrolidin-1-yl)ethyl]-5-methyl-2H-isoquinolin-1-one. The compound is (R)-3-[2-(2-hydroxymethylpyrrolidin-1-yl)ethyl]-5-methyl-2H-isoquinolin-1-one monophosphate. Compared to the free form and monohydrochloride dihydrate, this monophosphate is chemically stabler, has higher solubility, and changes less in weight with changing moisture. It is an excellent compound for use as a raw drug for medicines.
Patent AU-2009202420-B2 (AU)
Title: Improved Vaccines
Inventor: BUSCHLE MICHAEL
IPC: A61P31/00
Filed: 2009-06-17
Granted: 2012-04-26
Abstract: Abstract The invention refers to an improved vaccine against infections with pathogens, especially viral pathogens, comprising an antigen, a peptide of the formula R XZXZN-XZX-R 2 and an immunostimulatory deoxynucleic acid containing 5 deoxyinosine and/or deoxyuridine residues.
Patent AU-2009204825-B2 (AU)
Title: Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
Inventor: TEJBRANT JAN
IPC: A61K31/454
Filed: 2009-01-16
Granted: 2013-10-31
Abstract: The present invention relates to novel isoxazole compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers, tautomers, optical isomers or
Patent AU-2009252121-B2 (AU)
Title: Method and apparatus for managing tokens for digital rights management
Inventor: LEE KOOK-HEUI
IPC: G06F21/62
Filed: 2009-04-06
Granted: 2013-05-23
Abstract: A method and apparatus for managing tokens for Digital Rights Management (DRM) in a terminal are provided. In the method, at least one token is acquired from a Rights Issuer (RI), and the token is moved to a Secure Removable Media (SRM) through a token move request message. The token can be shared by several terminals.
Patent AU-2009260566-B2 (AU)
Title: Selective catalytic NOx reduction process and apparatus providing improved gasification of urea to form ammonia-containing gas
Inventor: LAU RONALD A
IPC: B01D53/56
Filed: 2009-05-27
Granted: 2013-08-22
Abstract: Disclosed are methods and apparatus enabling the efficient utilization of urea for purposes such as selective catalytic reduction (SCR) of NO